GIM
XERS icon

Granahan Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Granahan Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.12M Sell
898,753
-23,101
-3% -$148K 0.25% 96
2026
Q1 		$5.35M Sell
921,854
-301,550
-25% -$2M 0.26% 100
2025
Q4 		$9.6M Buy
1,223,404
+873,236
+249% +$6.87M 0.41% 63
2025
Q3 		$2.85M Buy
+350,168
New +$2.33M 0.12% 119
2022
Q2 		– Sell
-405,247
Closed -$1.04M – 191
2022
Q1 		$1.04M Sell
405,247
-119,365
-23% -$292K 0.03% 172
2021
Q4 		$1.54M Buy
524,612
+59,563
+13% +$129K 0.03% 179
2021
Q3 		$1.14M Buy
465,049
+14,635
+3% +$42.5K 0.02% 186
2021
Q2 		$1.83M Buy
450,414
+16,704
+4% +$63.7K 0.03% 180
2021
Q1 		$1.96M Buy
433,710
+121,120
+39% +$653K 0.04% 172
2020
Q4 		$1.54M Sell
312,590
-33,838
-10% -$169K 0.03% 180
2020
Q3 		$2.05M Buy
346,428
+6,025
+2% +$24.1K 0.07% 152
2020
Q2 		$905K Buy
+340,403
New +$1.19M 0.03% 172
2019
Q1 		– Sell
-82,504
Closed -$1.4M – 203
2018
Q4 		$1.4M Sell
82,504
-48,641
-37% -$976K 0.1% 149
2018
Q3 		$2.31M Buy
131,145
+445
+0.3% +$9.66K 0.13% 147
2018
Q2 		$2.48M Buy
+130,700
New +$2.54M 0.15% 150

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Granahan Investment Management's XERS Position: Q2 2026 in Review

Granahan Investment Management reduced its Xeris Biopharma Holdings (XERS) stake by 2.5% in Q2 2026, selling an estimated $148K and leaving 898,753 shares worth $7.12M. The position accounts for 0.25% of the portfolio, ranked #96.

Granahan Investment Management first reported a position in XERS in Q2 2018 and has held it in 15 quarters since. The position peaked at $9.6M in Q4 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Granahan Investment Management held 898,753 shares of Xeris Biopharma Holdings worth $7.12M as of Q2 2026.
  • Granahan Investment Management sold 23,101 Xeris Biopharma Holdings shares in Q2 2026, an estimated $148K.
  • Xeris Biopharma Holdings made up 0.25% of Granahan Investment Management's portfolio in Q2 2026, its #96 holding.
  • Granahan Investment Management first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 15 quarters since.
  • Granahan Investment Management's Xeris Biopharma Holdings position peaked at $9.6M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.